Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 16, Number 8—August 2010


Clostridium difficile Bacteremia, Taiwan1

CME Logo

Medscape, LLC is pleased to provide online continuing medical education (CME) for this journal article, allowing clinicians the opportunity to earn CME credit. This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is accredited by the ACCME to provide continuing medical education for physicians. Medscape, LLC designates this educational activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation at; (4) view/print certificate.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Identify presenting symptoms of Clostridium difficile bacteremia (CDB).

  • Specify the most common source of bacteremia in cases of CDB and incorporate that knowledge into the development of effective management plans.

  • Describe the prognosis of CDB.


Nancy Mannikko, MS, PhD, Technical Writer/Editor, Emerging Infectious Diseases. Disclosure: Nancy Mannikko, MS, PhD, has disclosed no relevant financial relationships.


Charles P. Vega, MD, Associate Professor; Residency Director, Department of Family Medicine, University of California, Irvine. Disclosure: Charles P. Vega, MD, has disclosed no relevant financial relationships.


Disclosures: Nan-Yao Lee, MD; Yu-Tsung Huang, MD; Po-Ren Hsueh, MD; and Wen-Chien Ko, MD, have disclosed no relevant financial relationships.


Article Navigation